Changeflow GovPing Government Integra LifeSciences Recalls MediHoney and CVS ...
Urgent Enforcement Removed Final

Integra LifeSciences Recalls MediHoney and CVS Wound Dressings

Favicon for www.fda.gov FDA MedWatch Safety Alerts
Detected March 7th, 2026
Email

Summary

The FDA announced a recall initiated by Integra LifeSciences for certain MediHoney and CVS Wound Gel products due to packaging failures that could lead to infection or delayed care. The recall involves removing affected products from service and distribution. Integra LifeSciences has reported 11 serious injuries related to MediHoney and three related to CVS Wound Gel.

What changed

The FDA is alerting the public about a recall initiated by Integra LifeSciences for specific MediHoney Wound and Burn products and certain lots of CVS Wound Gel. The recall is due to packaging failures that could compromise the sterile barrier, potentially leading to patient infections or delayed treatment. Integra LifeSciences has reported 11 serious injuries associated with the MediHoney products and three with the CVS Wound Gel products. No deaths have been reported.

Healthcare providers and distributors are instructed to immediately remove affected products from service and distribution channels, quarantine them, and notify customers. Distributors must follow specific procedures for collecting and reporting affected product quantities. Patients who have used the affected products and received standard operative care do not require additional follow-up. The FDA has determined that these devices may cause temporary or reversible health problems, or potentially serious health problems, though serious outcomes are unlikely.

What to do next

  1. Immediately remove affected MediHoney and CVS Wound Gel products from service and quarantine them.
  2. Notify customers and distributors about the recall and provide instructions for product return or disposal.
  3. Review internal inventory and distribution records to identify and segregate all affected product lots.

Source document (simplified)


The FDA has since determined that this device may cause temporary or reversible health problems, or—though unlikely—serious health problems. *The affected products and recommendations for what to do with the devices below have not changed. This*** recall involves removing certain devices from where they are used or sold.

Affected Product

The FDA is aware that Integra LifeSciences has issued a letter to affected customers recommending all MediHoney Wound and Burn products and certain lots of CVS Wound Gel be removed from where they are used or sold.

Affected devices:

| Product Name | SKU Number | UDI-DI | Lots |
| --- | --- | --- | --- |
| MEDIHONEY CALCIUM ALGINATE DRESS ROPE, ¾” X 12” | 31012 | 10381780486909 | All |
| MEDIHONEY CALCIUM ALGINATE DRESSING, 2” X 2” | 31022 | 10381780486916 | All |
| MEDIHONEY CALCIUM ALGINATE DRESSING, 4” X 5” | 31045 | 10381780486923 | All |
| MEDIHONEY GEL IN TUBE, .5 FL OZ TWISTOFF – STERILE | 31805 | 10381780486978 | All |
| MEDIHONEY GEL IN TUBE, 1.5 FL OZ FLIPCAP – STERILE | 31815 | 10381780486886 | All |
| CVS WOUND GEL 1 OZ. TUBE (28.4 g) 24 CARTONS/CASE | CVS405406 | 00050428452547 | 2446
2428 |

What to Do

Do not use affected product. Immediately identify and remove affected product from service.

On January 16, Integra LifeSciences sent all affected customers a letter recommending the following actions:

  • If you have units of the impacted product remove them immediately from service and quarantine them.
  • Forward this notice to those who utilize the product so they are aware of this recall and can identify any affected product that may remain in clinical areas.
  • If you have expired products, please ensure that you discard them per your facility’s policies and procedures and that you do not use them.
  • For Distributors:
    • Identify and remove affected product from further distribution.
    • Check your customer traceability records and notify them if they have any shipments of above catalog numbers.
    • Modify the acknowledgement form to create one from you to your customers.
    • Collect completed response forms and affected product from your customers and indicate total quantities and lots in distributor reply form.
    • Do not send the distributor form to your customers. Integra LifeSciences will not be able to directly assist your customers and will direct them back to you.

Reason for Recall

Integra LifeSciences identified packaging failures related to the MediHoney Wound and Burn products that could lead to a breach in the sterile barrier. Use of product with a breached sterile barrier could lead to patient infection. The inability to use the device due to packaging failures may delay care. If you have already used the products affected by this recall and standard operative care was followed, there is no additional patient follow-up required.

Integra LifeSciences identified production and process control issues for certain CVS Wound Gel products. If the affected product is used, it may lead to infection. Users may not be able to use the device due to packaging failures.

As of December 19, 2025, Integra LifeSciences has reported 11 serious injuries related to MediHoney Wound and Burn products, three serious injuries related to CVS Wound Gel products, and no deaths associated with this issue.

Device Use

MediHoney Wound and Burn products and CVS Wound Gel products are used for the treatment of burns and wounds. These products help maintain a moist wound environment, protect skin from breakdown and irritation, or protect the skin from damage.

Contact Information

Customers in the U.S. with adverse reactions, quality problems, or questions about this recall should contact Integra at 1-800-654-2873 or custsvcnj@integralife.com.

Additional FDA Resources

Unique Device Identifier (UDI)

The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

Timeline of Communication Updates

| Date | Actions |
| --- | --- |
| 03/06/2026 | The FDA updated this communication to inform the public that this issue has been classified as a Class II Recall. |
| 01/22/2026 | The FDA issued an Early Alert communication to notify the public of a potentially high-risk device issue. |

  • ## Content current as of:

03/06/2026

  • Regulated Product(s)

    • Medical Devices

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
Food and Drug Administration
Instrument
Enforcement
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers Distributors Manufacturers
Geographic scope
National (US)

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Product Recalls Patient Safety

Get Government alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA MedWatch Safety Alerts publishes new changes.

Free. Unsubscribe anytime.